Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03790280 · ClinicalTrials.gov registry record · NA
High Frequency Oscillation in Pediatric Epilepsy Surgery
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT03790280 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 17 participants.
The verdict
NCT03790280, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
High Frequency Oscillation (HFO) on ElectroCorticoGraphy (ECoG) has been identified as a new biomarker for epileptogenic tissue. The purpose of this study is to see if epilepsy surgery guided by the combination of HFO on ECoG and standard clinical practice can result in a greater likelihood of seizure freedom, versus standard clinical practice alone, without HFOs.
Interventions
- DIAGNOSTIC_TEST HFO analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2018-11-29 |
| Est. Completion | 2021-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03790280
The ClinicalTrials.gov registry entry for NCT03790280 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HFO analysis is the first listed.
NCT03790280 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03790280 about?
NCT03790280 is a clinical study titled "High Frequency Oscillation in Pediatric Epilepsy Surgery". High Frequency Oscillation (HFO) on ElectroCorticoGraphy (ECoG) has been identified as a new biomarker for epileptogenic tissue. The purpose of this study is to see if epilepsy surgery guided by the combination of HFO on ECoG and standard clinical practice can result in a greater likelihood of seizu...
What is the current status of trial NCT03790280?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2018-11-29. Estimated completion is 2021-07-01.
What interventions are being tested in trial NCT03790280?
The interventions under investigation include: HFO analysis (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03790280?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.